FI861330A0 - 4-(isoxazolyl)-tiazol-2-oxaminsyror och deras derivat. - Google Patents

4-(isoxazolyl)-tiazol-2-oxaminsyror och deras derivat.

Info

Publication number
FI861330A0
FI861330A0 FI861330A FI861330A FI861330A0 FI 861330 A0 FI861330 A0 FI 861330A0 FI 861330 A FI861330 A FI 861330A FI 861330 A FI861330 A FI 861330A FI 861330 A0 FI861330 A0 FI 861330A0
Authority
FI
Finland
Prior art keywords
oxaminsyror
tiazole
isoxazolyl
derivatives
Prior art date
Application number
FI861330A
Other languages
English (en)
Other versions
FI861330A (fi
FI83650C (fi
FI83650B (fi
Inventor
Angelo Carenzi
Dario Chiarino
Davide Della Bella
Giancarlo Grancini
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of FI861330A publication Critical patent/FI861330A/fi
Publication of FI861330A0 publication Critical patent/FI861330A0/fi
Application granted granted Critical
Publication of FI83650B publication Critical patent/FI83650B/fi
Publication of FI83650C publication Critical patent/FI83650C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
FI861330A 1984-07-31 1986-03-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat. FI83650C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT2215084 1984-07-31
IT22150/84A IT1183061B (it) 1984-07-31 1984-07-31 Composti dotati di attivita'antiallergica
EP8500381 1985-07-30
PCT/EP1985/000381 WO1986000900A1 (en) 1984-07-31 1985-07-30 4-(isoxazolyl)-thiazole-2-oxamic acids and derivatives thereof

Publications (4)

Publication Number Publication Date
FI861330A FI861330A (fi) 1986-03-26
FI861330A0 true FI861330A0 (fi) 1986-03-26
FI83650B FI83650B (fi) 1991-04-30
FI83650C FI83650C (fi) 1991-08-12

Family

ID=11192238

Family Applications (2)

Application Number Title Priority Date Filing Date
FI861329A FI85473C (fi) 1984-07-31 1986-03-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat och mellanprodukter.
FI861330A FI83650C (fi) 1984-07-31 1986-03-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI861329A FI85473C (fi) 1984-07-31 1986-03-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat och mellanprodukter.

Country Status (13)

Country Link
US (2) US4766137A (fi)
EP (2) EP0190298B1 (fi)
JP (2) JPS61502959A (fi)
AU (2) AU583847B2 (fi)
CA (2) CA1243318A (fi)
DE (2) DE3573781D1 (fi)
DK (2) DK164364C (fi)
ES (4) ES8703459A1 (fi)
FI (2) FI85473C (fi)
IL (1) IL75981A (fi)
IT (1) IT1183061B (fi)
WO (2) WO1986000899A1 (fi)
ZA (1) ZA855743B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183061B (it) * 1984-07-31 1987-10-05 Zambon Spa Composti dotati di attivita'antiallergica
IT1204960B (it) * 1987-03-25 1989-03-10 Zambon Farmaceutici Spa Composti dotati di attivita' antiallergica
US4946963A (en) * 1987-11-13 1990-08-07 The University Of North Carolina At Chapel Hill Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones
DE3844227A1 (de) * 1988-12-29 1990-07-05 Basf Ag 3(2h)-pyridazinonderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
DE19638667C2 (de) 1996-09-20 2001-05-17 Osram Opto Semiconductors Gmbh Mischfarbiges Licht abstrahlendes Halbleiterbauelement mit Lumineszenzkonversionselement
DE19625622A1 (de) * 1996-06-26 1998-01-02 Siemens Ag Lichtabstrahlendes Halbleiterbauelement mit Lumineszenzkonversionselement
KR100629544B1 (ko) 1996-06-26 2006-09-27 오스람 게젤샤프트 미트 베쉬랭크터 하프퉁 발광 변환 소자를 포함하는 발광 반도체 소자
TWI349550B (en) 2003-12-26 2011-10-01 A thiazole derivative and adenosine a2a receptor antagonist containing the same
EP1988077A4 (en) * 2006-02-23 2009-09-02 Shionogi & Co NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2429210A1 (fr) * 1978-06-19 1980-01-18 Fabre Sa Pierre Derives de phenyl-4 thiazolyl-2 oxamates utiles dans le traitement de l'asthme
DE3027527A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
FR2494272A1 (fr) * 1980-11-19 1982-05-21 Fabre Sa Pierre Derives de l'acide thiazolyl-2 oxamique substitues en position 4 par un radical thienyle ou furyle, leur preparation et leur utilisation comme medicaments
IT1183061B (it) * 1984-07-31 1987-10-05 Zambon Spa Composti dotati di attivita'antiallergica

Also Published As

Publication number Publication date
EP0190298A1 (en) 1986-08-13
CA1261847C (fi) 1989-09-26
ES8800217A1 (es) 1987-10-16
FI85473B (fi) 1992-01-15
FI861330A (fi) 1986-03-26
FI85473C (fi) 1992-04-27
DK142086D0 (da) 1986-03-26
CA1243318A (en) 1988-10-18
ZA855743B (en) 1986-05-28
IL75981A (en) 1989-07-31
AU4671785A (en) 1986-02-25
JPS61502959A (ja) 1986-12-18
JPH0576946B2 (fi) 1993-10-25
JPH0574592B2 (fi) 1993-10-18
EP0191045B1 (en) 1989-12-20
JPS61502896A (ja) 1986-12-11
ES8608516A1 (es) 1986-07-16
IL75981A0 (en) 1985-12-31
ES8703459A1 (es) 1987-02-16
DK142086A (da) 1986-05-29
AU583847B2 (en) 1989-05-11
FI861329A0 (fi) 1986-03-26
DK141986D0 (da) 1986-03-26
ES546419A0 (es) 1987-02-16
IT1183061B (it) 1987-10-05
FI83650C (fi) 1991-08-12
FI83650B (fi) 1991-04-30
DK164364B (da) 1992-06-15
DE3573781D1 (en) 1989-11-23
ES546420A0 (es) 1986-07-16
AU584118B2 (en) 1989-05-18
EP0190298B1 (en) 1989-10-18
FI861329A (fi) 1986-03-26
ES552513A0 (es) 1987-10-16
DK141986A (da) 1986-05-28
EP0191045A1 (en) 1986-08-20
US4766137A (en) 1988-08-23
AU4724885A (en) 1986-02-25
US4766138A (en) 1988-08-23
ES552514A0 (es) 1987-05-01
CA1246583A (en) 1988-12-13
WO1986000900A1 (en) 1986-02-13
WO1986000899A1 (en) 1986-02-13
DE3574874D1 (de) 1990-01-25
ES8705434A1 (es) 1987-05-01
DK164364C (da) 1992-11-02
IT8422150A0 (it) 1984-07-31

Similar Documents

Publication Publication Date Title
FI853206L (fi) Heterocykliska derivat.
FI884966A0 (fi) N-substituerade derivat av 1-desoxinojirimycin och desoximannonojirimycin, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI891839A0 (fi) Stabiliserade synnerligen omaettade fettsyror och derivat av saodana syror.
FI882888A0 (fi) Medelst loesningsmedelsfria reaktioner framstaellda ympkopolymerer och dispergerande derivat daerav.
FI861357A (fi) Derivat av metylenbisfosfonsyra, foerfarande foer deras framstaellning och en faramceutisk blandning.
FI891122A0 (fi) N-cyklopropylaniliner och deras anvaendning i foerfarandet foer framstaellning av 1-cyklopropylkinolonkarboxylsyror och deras derivat.
FI885424A (fi) Diacylderivat av 4-(trialkylbensyl) -piperazinylfoereningar.
FI891123A (fi) Foerfarande foer framstaellning av 1 -cyklopropylkinolonkarboxylsyror och deras derivat.
FI904838A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva karboxitetrahydroisokinoliner och deras derivat.
FI890645A0 (fi) Kloning och expression av maenniskans vaevnadsfaktor.
FI851459L (fi) Derivat av hydroxi-4-2h-1 -benzotiopyran-2-on, deras framstaellning och anvaendning.
FI861330A0 (fi) 4-(isoxazolyl)-tiazol-2-oxaminsyror och deras derivat.
FI902082A0 (fi) Stereoselektiv framstaellning av 3-substituerade 4-anilinopiperidinfoereningar och derivat.
FI883392A0 (fi) Loesliga derivat av silybin, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaollande dessa.
FI883680A (fi) Foerfarande foer behandling av illamaoende med vissa substituerade fenylalkylamino (och aminosyra) derivat.
FI883771A (fi) 3-(substituerad) propenyl-7 -(aminotiazolylacetamido) cef-3-em-4-karboxylsyror och estrar daerav.
FI895621A0 (fi) Foerfarande foer framstaellning av till kristallstrukturen laongstraedet kalciumsulfat med kontrollerad laengd och formfaktor.
FI885754A (fi) Foerfarande och anordning foer konvertering av energi fraon en omgivning till elenergi.
FI890256A (fi) Foerfarande foer framstaellning av flytande konstruktioner och flytande element foer foerfarandet.
FI862942A0 (fi) Embonat av kinolonkarbonsyror och deras derivat.
FI851444A0 (fi) Kefalosporin derivat och salter daerav.
FI870896A0 (fi) Foerfarande foer framstaellning av fosfonyloxiacylaminosyror och deras derivat.
FI873273A (fi) Kefalosporiner och derivat.
FI883904A0 (fi) Foerfarande och anordning i en pappers- eller kartongmaskin foer ledande av banan fraon virapartiet till presspartiet.
FI871277A0 (fi) Foerfarande och element foer framstaellning av baoghall.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: ZAMBON S.P.A.